Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology
NCT00801762 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 195
Last updated 2019-04-22
Summary
The goal of the study is to develop a novel approach to obtain real time optical biopsy of urinary tract pathology (e.g., bladder tumors) during urinary tract endoscopy using a novel fibered confocal microscope.
Conditions
Interventions
- DEVICE
-
Fibered confocal microscope
Sponsors & Collaborators
-
Mauna Kea Technologies
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Joseph C. Liao · Stanford University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2015-02-28
- Completion
- 2015-02-28
Countries
- United States
Study Locations
More Related Trials
-
Confocal Laser Endomicroscopy During TransUrethral Resection for Improving BC Diagnosis and Treatment
NCT05273593 ·Status: COMPLETED ·Phase: NA
-
Microscopic-spectroscopic Examination for Urothelial Tissue Characterization
NCT04310813 ·Status: COMPLETED
-
Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer
NCT06972771 ·Status: RECRUITING
-
Endoscopic Subsurface Optical Imaging for Cancer Detection
NCT01810445 ·Status: COMPLETED
-
Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
NCT00233402 ·Status: COMPLETED ·Phase: PHASE3
-
Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
NCT07029256 ·Status: RECRUITING
-
Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer
NCT05600322 ·Status: COMPLETED ·Phase: PHASE3
-
Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancers
NCT06087016 ·Status: RECRUITING
-
Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
NCT07180212 ·Status: RECRUITING ·Phase: NA
-
A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer
NCT00412971 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer
NCT01563796 ·Status: TERMINATED
-
Confocal Laser Endomicroscopy in the Lower Urinary Tract
NCT03013894 ·Status: COMPLETED
-
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
NCT02560584 ·Status: COMPLETED ·Phase: PHASE3
-
Can Four Weeks-check Cystoscopy and Urine Cytology After Primary Complete Resection of T1 Bladder Cancer Replace Repeat Biopsy?
NCT05167916 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
NCT00872495 ·Status: RECRUITING
-
The Combined Role of FAPI PET and Liquid Biopsy in the Staging and Clinical Management of Bladder Cancer - FUTURE Trial
NCT07257718 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors
NCT03238664 ·Status: WITHDRAWN ·Phase: NA
-
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
NCT06310759 ·Status: RECRUITING
-
Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11)
NCT03617003 ·Status: COMPLETED ·Phase: PHASE1
-
Detection of Disease in the Upper Tract
NCT05349812 ·Status: WITHDRAWN
-
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
NCT03193515 ·Status: RECRUITING
-
Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment
NCT06679920 ·Status: RECRUITING ·Phase: NA
-
Detection of K14 in Bladder Cancer With a Non Invasive Technique
NCT02027649 ·Status: TERMINATED
-
Near Infrared Fluorescence Imaging for Bladder Cancer Detection
NCT03058705 ·Status: COMPLETED ·Phase: NA
-
Identifying Methylation Biomarkers for Monitoring Bladder Tumors
NCT00244205 ·Status: UNKNOWN